Vascular Medicine Conference-CVC 2026

Anticoagulation, in essence, involves the administration of medications designed to decrease the blood’s tendency to form clots—an intervention crucial for preventing or managing conditions such as deep vein thrombosis, pulmonary embolism, and strokes associated with atrial fibrillation. Common agents include warfarin, heparin, and direct oral anticoagulants (DOACs), each presenting their own set of indications, dosing protocols, and monitoring considerations.

Effective anticoagulation therapy requires vigilant adherence to prescribed regimens, thorough monitoring, and prompt recognition of adverse effects, particularly bleeding complications. Dietary factors, lifestyle habits, and drug interactions all play significant roles in influencing therapeutic outcomes. Additionally, in contexts like surgical procedures, clinicians may employ bridging strategies or temporarily halt anticoagulation to balance the risks of thrombosis and bleeding. When managed appropriately, anticoagulation therapy significantly reduces the incidence of serious thromboembolic events and contributes to improved long-term vascular health.